These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21512274)

  • 41. Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.
    Ghosn S; Chamat S; Prieur E; Stephan A; Druilhe P; Bouharoun-Tayoun H
    Front Immunol; 2018; 9():601. PubMed ID: 29628927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
    Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
    Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1.
    Sato K; Nie C; Misawa N; Tanaka Y; Ito M; Koyanagi Y
    Vaccine; 2010 May; 28 Suppl 2():B32-7. PubMed ID: 20510741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
    Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
    J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation.
    Bueno C; Montes R; de la Cueva T; Gutierrez-Aránda I; Menendez P
    Cytotherapy; 2010; 12(1):45-9. PubMed ID: 19929453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Generation of a new strain of NOD/SCID/IL2Rγ
    Liu YC; Chen Q; Yang XL; Tang QS; Yao KT; Xu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):639-646. PubMed ID: 29997084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Preconditioning of Busulfan Promotes Efficiency of Human CD133+ Cells Engraftment in NOD Shi-SCID IL2Rγcnull (NOG) Mice via Intra-Bone Marrow Injection.
    Guo X; Yin X; Zhu W; Pan Y; Wang H; Liang Y; Zhu X
    Cell Transplant; 2019 Jul; 28(7):973-979. PubMed ID: 30983406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse.
    Katano I; Nishime C; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M; Takahashi T
    Sci Rep; 2017 Dec; 7(1):17230. PubMed ID: 29222435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
    Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
    Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
    Suzuki M; Takahashi T; Katano I; Ito R; Ito M; Harigae H; Ishii N; Sugamura K
    Int Immunol; 2012 Apr; 24(4):243-52. PubMed ID: 22402880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
    Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
    J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model.
    Masaki A; Ishida T; Suzuki S; Ito A; Mori F; Sato F; Narita T; Yamada T; Ri M; Kusumoto S; Komatsu H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R
    J Immunol; 2013 Jul; 191(1):135-44. PubMed ID: 23733874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID mice.
    Moreau T; Bardin F; Barlogis V; Le Deist F; Chabannon C; Tonnelle C
    Cytotherapy; 2009; 11(2):198-205. PubMed ID: 19235603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody repertoires in humanized NOD-scid-IL2Rγ(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse.
    Ippolito GC; Hoi KH; Reddy ST; Carroll SM; Ge X; Rogosch T; Zemlin M; Shultz LD; Ellington AD; Vandenberg CL; Georgiou G
    PLoS One; 2012; 7(4):e35497. PubMed ID: 22558161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses.
    Yaguchi T; Kobayashi A; Inozume T; Morii K; Nagumo H; Nishio H; Iwata T; Ka Y; Katano I; Ito R; Ito M; Kawakami Y
    Cell Mol Immunol; 2018 Nov; 15(11):953-962. PubMed ID: 29151581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma.
    Wang G; Ishikawa H; Sone K; Kobayashi T; Kim JJ; Kurita T; Shozu M
    Fertil Steril; 2014 May; 101(5):1485-92. PubMed ID: 24636398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
    Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
    Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
    Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab.
    Jodeleit H; Caesar J; Villarroel Aguilera C; Sterz S; Holdt L; Beigel F; Stallhofer J; Breiteneicher S; Bartnik E; Siebeck M; Gropp R
    Inflamm Bowel Dis; 2020 Mar; 26(4):557-569. PubMed ID: 31782956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced Antibody Responses in a Novel NOG Transgenic Mouse with Restored Lymph Node Organogenesis.
    Takahashi T; Katano I; Ito R; Goto M; Abe H; Mizuno S; Kawai K; Sugiyama F; Ito M
    Front Immunol; 2017; 8():2017. PubMed ID: 29387068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.